14 Panel Dip Card
The 14 panel dip card is a fast, reliable, and easy-to-use urine screening device designed to
detect ten commonly abused drugs in a single test format. This multi-drug detection dip card
is widely used in workplaces, rehabilitation programs, probation monitoring, healthcare screening,
law enforcement, and personal testing where accurate and efficient drug screening is required.
Showing all 5 results
14 Panel Multi Dip card with PCP, ETG, FEN & ADLTX
ADLTX, AMP, BAR, BUP, BZO, COC, EtG, FEN, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THCForensic UseAs low As$1.39 $1.39 - $1.89
Dip card 14 Panel Detects KRA, K2, ETG & FEN, Serenity Multi-Level Dip Card
AMP, BUP, BZO, COC, EtG, FEN, K2, KRA, MDMA, MET, MTD, OPI/MOR, OXY, THCForensic UseAs low As$1.39 $1.39 - $1.89
Dip card 14 Panel Detects ETG & FEN, Serenity Multi Dip Card
AMP, BAR, BUP, BZO, COC, EtG, FEN, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THCForensic UseAs low As$1.39 $1.39 - $1.89
Dip card 14 Panel Detects PCP, ETG & KRA, Serenity Multi Level Dip Card
AMP, BAR, BUP, BZO, COC, EtG, FEN, KRA, MDMA, MET, MTD, OPI/MOR, OXY, PCPForensic UseAs low As$1.39 $1.39 - $1.89
Dip Card 14 Panel Detects PCP, ETG, FEN & Adulterants
ADLTX, AMP, BAR, BUP, BZO, COC, EtG, FEN, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THCForensic UseAs low As$1.39 $1.39 - $1.89
Bulk Pricing that Cuts the Budget in Half
Priority Shipping For Bulk Orders.
Dedicated Wholesale Representative.
Quality That Is Reliable For the Nation.
Key Features of 14 Panel Dip Card
Five Serenity 14 Panel Multi-Level Dip Cards from $1.39 in bulk. EtG and FEN are standard across all five configurations. Each 14 Panel dip card adds a distinct combination of PCP, KRA, K2, BAR, and ADLTX specimen validity to match different program substance monitoring profiles. All Forensic Use Only. Results in 5 minutes. Same-day shipping.
- Rapid results – preliminary screening complete in 5 to 10 minutes for 6 types of drugs and variants
- Fully observed collection – tamper-resistant process with no restroom needed
- On-site ready – no lab, no special equipment, no collection facility required
- Detects recent use – identifies drug use within the past 24 to 48 hours
- Minimal training required – straightforward administration for any staff member
- Individually sealed sterile devices – hygienic single-use packaging for every test
14 Panel Multi Dip Card Test specifications
| Code | Substance | Cutoff | What It Catches |
|---|---|---|---|
| AMP | Amphetamines | 1000 ng/mL | Adderall, Vyvanse, prescription and illicit amphetamines — standard across all five cards |
| BAR | Barbiturates | 300 ng/mL | Phenobarbital, butalbital, secobarbital — present on four of five cards; absent on K2/KRA card |
| BUP | Buprenorphine | 10 ng/mL | Suboxone, Subutex at MAT therapeutic concentrations — standard across all five cards |
| BZO | Benzodiazepines | 300 ng/mL | Xanax, Valium, Klonopin, Ativan — standard across all five cards |
| COC | Cocaine | 300 ng/mL | Cocaine, crack cocaine — standard across all five cards |
| EtG | Ethyl Glucuronide | 300 ng/mL | Alcohol metabolite up to 80 hours post-consumption — standard across all five cards |
| FEN | Fentanyl | 20 ng/mL | Illicit fentanyl and primary fentanyl analogs — added to SAMHSA federal panels July 2025 — standard across all five cards |
| K2 | Synthetic Cannabinoids | 50 ng/mL | K2, Spice — does not cross-react with THC. Present only on the KRA/K2/EtG/FEN card |
| KRA | Kratom | 500 ng/mL | Mitragyna speciosa — opioid receptor activity, passes all OPI/BUP/MTD panels. Present on two cards |
| MDMA | MDMA / Ecstasy | 500 ng/mL | Ecstasy, Molly — independent dedicated panel — standard across all five cards |
| MET | Methamphetamine | 1000 ng/mL | Crystal meth, street methamphetamine — standard across all five cards |
| MTD | Methadone | 300 ng/mL | Methadone maintenance — does not appear on standard OPI strip — standard across all five cards |
| OPI/MOR | Opiates / Morphine | 300 ng/mL | Heroin, codeine, morphine — standard across all five cards |
| OXY | Oxycodone | 100 ng/mL | OxyContin, Percocet — does not appear on standard OPI strip — standard across all five cards |
| PCP | Phencyclidine | 25 ng/mL | PCP, angel dust — present on four of five cards; absent on K2/KRA card |
| THC | Marijuana / Cannabis | 50 ng/mL | Cannabis, edibles, concentrates — present on four of five cards; absent on PCP/EtG/KRA card |
| ADLTX — Specimen Validity Checks (built into two of the five cards) | |||
| pH | Urine pH | 3.0 to 11.0 | Flags chemical adulteration outside normal urinary pH range |
| SG | Specific Gravity | 1.001 to 1.030 | Detects diluted or substituted specimens |
| CRE | Creatinine | 2 to 300 mg/dL | Confirms biological origin of the specimen |
EtG and FEN are the two panels present across every configuration. Red codes appear on only one or two of the five cards. ADLTX runs on the two "Adulterants" cards only. See variant table below.
Choose Your 14 Panel Configuration
| Product | All Panels | Type | Unique Add-Ons | From |
|---|---|---|---|---|
| 14 Panel with PCP, EtG, FEN and ADLTX Best for court, corrections, probation needing specimen validity + FEN |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | PCP/25ng MDMA | MET | MTD | OPI/MOR | OXY | THC + pH | Specific Gravity | Creatinine |
Forensic Use Only | BAR + PCP + EtG + FEN + ADLTX | $1.39 |
| 14 Panel with KRA, K2, EtG and FEN Best for treatment, corrections, sober living needing Kratom and K2 detection |
AMP | BUP | BZO | COC EtG/300ng | FEN/20ng | K2/50ng | KRA/500ng MDMA | MET | MTD | OPI/MOR | OXY | THC No BAR, No PCP, No ADLTX |
Forensic Use Only | K2 + KRA + EtG + FEN | $1.39 |
| 14 Panel with EtG and FEN Best for workplace, MAT, drug courts needing clean baseline + alcohol + fentanyl |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | PCP/25ng MDMA | MET | MTD | OPI/MOR | OXY | THC No ADLTX, No KRA, No K2 |
Forensic Use Only | BAR + PCP + EtG + FEN | $1.39 |
| 14 Panel with PCP, EtG and KRA (no THC) Best for programs prioritising Kratom monitoring over cannabis screening |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | KRA/500ng | PCP/25ng MDMA | MET | MTD | OPI/MOR | OXY No THC, No ADLTX, No K2 |
Forensic Use Only | BAR + PCP + EtG + FEN + KRA | $1.39 |
| 14 Panel with PCP, EtG, FEN and Adulterants Best for forensic and legal programs requiring documented specimen validity |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | PCP/25ng MDMA | MET | MTD | OPI/MOR | OXY | THC + pH | Specific Gravity | Creatinine |
Forensic Use Only | BAR + PCP + EtG + FEN + ADLTX | $1.39 |
All five cards require a separate urine collection container. Results in 5 minutes. 99% accuracy. Forensic Use Only — all presumptive positive results require GC-MS or LC-MS/MS confirmation. For bulk pricing call 561-897-9238 or email [email protected].
Easy Steps To Use The 14 Panel Dip Card
Step 1 — Collect
Remove the drug test cup from its sealed pouch and use it as soon as possible. Have the subject provide a urine sample directly into the cup, filling to the indicated line.
Step 2 — Dip & Wait
At 2–4 minutes, verify the temperature of the specimen using the built-in temperature strip. A green indicator confirms the sample is valid and within the acceptable range of 90–100°F.
Step 3 — Read
Peel back the label when ready to interpret results. Read results within 5 minutes of collection. Do not read results after 8 minutes, as the extended window may affect accuracy.
Positive
Two colored bands appear — one in the control region (C) and one in the test region (T). This indicates no drug was detected above the cutoff level.
Negative
Two colored bands appear, one in the control region (C) and another in the test region (T) for the drug in question.
Invalid
The control band fails to appear entirely. Discard the test and retest with a fresh cup within 3 minutes. If the problem persists, contact your distributor.
What is Included in a 14 Panel Dip Cards and its Variatios
The 14 panel dip card category from 12 Panel Now contains five distinct Serenity Multi-Level Dip Cards, all at $1.39 per card in bulk and all Forensic Use Only. Two panels are constant across every configuration: Ethyl Glucuronide (EtG) at 300 ng/mL for alcohol monitoring and Fentanyl (FEN) at 20 ng/mL per the July 2025 SAMHSA federal mandate. The eleven core professional substance panels (AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY) are also standard across all five. The difference between the five cards lies in which specialty panels fill the remaining positions and whether ADLTX specimen validity is included.
What separates the five 14 panel configurations:
14 Panel with PCP, EtG, FEN and ADLTX (Multi Dip Card)
AMP, BAR, BUP, BZO, COC, EtG/300, FEN/20, MDMA, MET, MTD, OPI/MOR, OXY, PCP/25, THC plus ADLTXThe classical 12 panel professional baseline (BAR and PCP included) plus EtG at 300 ng/mL and FEN at 20 ng/mL, with the three-marker ADLTX specimen validity check built in. This is the highest-integrity configuration in the range: 14 drug panels covering every standard professional substance class plus alcohol monitoring and fentanyl, with pH, Specific Gravity, and Creatinine validity checks running simultaneously. For programs where specimen integrity documentation is a legal requirement alongside comprehensive standard substance and fentanyl screening, this configuration provides everything in one $1.39 card.
14 Panel with KRA, K2, EtG and FEN
AMP, BUP, BZO, COC, EtG/300, FEN/20, K2/50, KRA/500, MDMA, MET, MTD, OPI/MOR, OXY, THC. No BAR, No PCP, No ADLTXThis configuration replaces BAR and PCP with Kratom (KRA) at 500 ng/mL and K2 Synthetic Cannabinoids at 50 ng/mL — two substances that pass every standard multi-panel screen. No ADLTX validity checks. No BAR or PCP. KRA detects kratom, which acts on mu-opioid receptors but does not trigger any OPI, BUP, or MTD panel. K2 detects synthetic cannabinoids that return a negative on every THC panel. For treatment programs, MAT clinics, and sober living facilities where Kratom and K2 use are documented alongside fentanyl and alcohol monitoring requirements, this card closes four detection gaps that no standard 12 panel card can address — in a single $1.39 dip.
14 Panel with EtG and FEN (Standard Baseline)
AMP, BAR, BUP, BZO, COC, EtG/300, FEN/20, MDMA, MET, MTD, OPI/MOR, OXY, PCP/25, THC. No ADLTX, No KRA, No K2The cleanest configuration in the range: the complete 12 panel professional baseline (AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC) plus EtG and FEN as the 13th and 14th panels. No ADLTX. No specialty additions beyond EtG and FEN. For programs that need the standard professional baseline with alcohol monitoring and fentanyl detection — and nothing more — this is the appropriate card. The absence of ADLTX makes it the right choice for programs not requiring documented specimen validity from the card itself.
14 Panel with PCP, EtG and KRA (no THC)
AMP, BAR, BUP, BZO, COC, EtG/300, FEN/20, KRA/500, MDMA, MET, MTD, OPI/MOR, OXY, PCP/25. No THC, No ADLTX, No K2This configuration adds Kratom (KRA) at 500 ng/mL and retains PCP, BAR, EtG, and FEN, but removes THC from the panel position to accommodate KRA in the 14-substance count. This is the card for programs where kratom monitoring and PCP coverage are higher priorities than cannabis screening — correctional programs operating in jurisdictions where cannabis is legal but Kratom use is a documented institutional concern, or forensic programs with supervision orders that specify kratom monitoring but do not require cannabis documentation. THC is not included. ADLTX is not included.
14 Panel with PCP, EtG, FEN and Adulterants
ADLTX, AMP, BAR, BUP, BZO, COC, EtG/300, FEN/20, MDMA, MET, MTD, OPI/MOR, OXY, PCP/25, THC. No KRA, No K2This card has the same drug panel composition as the EtG/FEN card (Product 3) but adds ADLTX built-in specimen validity (pH, Specific Gravity, Creatinine). The 14 drug panels are identical: AMP, BAR, BUP, BZO, COC, EtG, FEN, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC. The ADLTX check adds documented specimen integrity confirmation for programs where legal proceedings or regulatory documentation require validity evidence alongside the drug screening result. For forensic programs choosing between this card and the EtG/FEN card (Product 3), the decision is entirely based on whether ADLTX specimen validity documentation is required.
The Two Constants Across All Five Cards: EtG and FEN
Every 14 panel card in this range includes both EtG at 300 ng/mL and FEN at 20 ng/mL as non-negotiable baseline additions over any standard 12 panel configuration. EtG closes the alcohol monitoring gap across the inter-test interval. FEN closes the fentanyl detection gap per the July 2025 federal mandate. Every program selecting from this range gets both capabilities regardless of configuration. The five cards then differentiate on which of PCP, BAR, KRA, K2, and ADLTX are added to those two constants within the 14 panel count.
14 Panel Dip Card Features: EtG and FEN As Low As $1.39
Five 14 Panel Drug Test Dip Cards from 12 Panel Now: EtG and FEN Standard, Five Distinct Specialty Panel Combinations at $1.39 in Bulk: The 14 panel dip card range delivers alcohol monitoring via EtG and fentanyl detection via FEN as a non-negotiable baseline across all five configurations, then offers five distinct specialty panel combinations that match five different forensic program substance monitoring profiles.
- EtG at 300ng/mL and FEN at 20ng/mL Standard Across All Five Cards: The Two Most Important Additions Over a 12 Panel Baseline: EtG at 300 ng/mL detects alcohol consumption for up to 80 hours post-use — covering the full weekly inter-test interval for programs running weekly collections. FEN at 20 ng/mL detects illicit fentanyl per the July 2025 SAMHSA federal mandate. Every card in this range closes both gaps simultaneously over the standard 12 panel baseline — no configuration selection required for these two capabilities.
- KRA at 500ng/mL on Two Cards: Kratom Detection in a 14 Panel Format: Two configurations in this range include Kratom (KRA) at 500 ng/mL: the K2/KRA card and the PCP/KRA card. Kratom acts on mu-opioid receptors but produces no result on any standard OPI, BUP, or MTD panel. Legally sold at retail in most US states, it is documented as a self-managed opioid substitute in treatment and forensic populations. Per NIDA research on herbal substances, kratom's opioid receptor activity and dependence potential make it a significant monitoring gap in standard screening programs.
- K2 at 50ng/mL on One Card: Synthetic Cannabinoid Detection That No THC Strip Can Provide: The K2/KRA/EtG/FEN card is the only configuration in this range with a dedicated K2 Synthetic Cannabinoid panel at 50 ng/mL. K2 compounds return a completely negative result on any THC panel at any cutoff because K2 and THC are chemically distinct. Per NIDA K2/Spice research, synthetic cannabinoids are significantly documented in correctional and residential recovery populations.
- ADLTX Built In on Two Cards: Documented Specimen Validity Alongside Every Drug Result: The two ADLTX cards (PCP/EtG/FEN/ADLTX Multi Dip Card and PCP/EtG/FEN/Adulterants) include pH, Specific Gravity, and Creatinine running simultaneously with all 14 drug panels. For forensic programs where results enter legal proceedings — drug court revocation hearings, probation violations, correctional discipline proceedings — documented specimen validity is a legal protection. The ADLTX markers run in the same 5-minute dip event, producing simultaneous drug and validity evidence on the same card with no additional strip required.
- Complete Opioid Class Coverage Across All Five Cards — BUP, MTD, OPI/MOR and OXY All Standard: BUP at 10 ng/mL (Suboxone and Subutex), MTD at 300 ng/mL (methadone maintenance), OPI/MOR at 300 ng/mL (heroin, codeine, morphine), and OXY at 100 ng/mL (Percocet, OxyContin) are all standard across every 14 panel configuration. No opioid class gap exists in any card in this range — every configuration covers the complete four-panel opioid class baseline simultaneously.
- From $1.39 Per Card in Bulk, Same-Day Shipping, 10% Price Beat Guarantee: All five 14 panel dip card configurations are at $1.39 per card with tiered wholesale pricing at every volume level. Mix any combination of the five configurations on a single order. Send your current supplier's pricing to [email protected] and we beat it by 10%. Same-day shipping on all orders before 3:00 PM EST. Full OEM and private label available across all five configurations.
Contact for Bulk 14 Panel Dip Card Orders, Wholesale Pricing and Private Label: 561-897-9238 | [email protected]
Check other product variations
for Multi Dip Cards
From everyday staples to specialty products:
- Multi Strips
- 5 Panel Dip Cards
- 10 Panel Dip Cards
- 12 Panel Dip Cards
- 14 Panel Dip Cards
- 19 Panel Dip Cards
10 Panel Dip
13 Dip Panel
12 Panel Dip
Dip Cards
Buy in Bulk from 12 Panel Now and Get 10% off.
- Five configurations, all at $1.39: PCP/EtG/FEN/ADLTX Multi Dip Card, KRA/K2/EtG/FEN, EtG/FEN standard baseline, PCP/EtG/KRA (no THC), and PCP/EtG/FEN/Adulterants
- EtG and FEN standard on all five. ADLTX on two cards. KRA on two cards. K2 on one card. PCP and BAR on four of five. THC on four of five
- All Forensic Use Only. Results in 5 minutes. 99% accuracy. Same-day shipping. 1 to 2 year shelf life. 10% price beat on any competing quote
- Full OEM and private label for drug courts, corrections, treatment programs, sober living, and distributors
Upgrading from 13 panel? The 13 panel dip card range at $1.29 provides the 12 panel baseline plus FEN and EtG or TCA/BAR. The 14 panel range at $1.39 adds a further specialty panel (KRA, K2, PCP, or ADLTX) to that foundation. Need even more panels? See the 15 panel dip card range adding Gabapentin.
Order 14 Panel Dip Cards in Bulk Today 561-897-9238 [email protected]
What 12 Panel Now Offers:
220,000 Sq. Ft. Mega
Warehouse
We operate one of the largest drug-testing fulfillment centers in the country, stocked and ready to ship every day.
Lowest Wholesale Pricing. Highest Commissions. Period.
We aggressively price our products so you win more deals, while paying industry-leading commissions to our partners.
Same-Day Blind Drop Shipping
We ship directly to your customers — no branding, no invoices, no paper trail back to us. You keep the relationship. We do the heavy lifting.
Private Label Available
Want your own brand on the box? We’ve got you covered.
Build equity while selling proven products.
Real-Time Partner Portal
Track every order, commission, and customer in one clean dashboard. No guessing. No spreadsheets. Total transparency.
Where 14 Panel Dip Cards Are Used
| Setting | Best Card | Primary Applications | Why This Card |
| Drug Courts and Probation | 14 Panel PCP/EtG/FEN/Adulterants | Court-ordered comprehensive substance monitoring with 80-hour alcohol abstinence documentation (EtG), fentanyl detection (FEN), PCP coverage required in many forensic supervision orders, and documented specimen validity (ADLTX) for legal proceedings | ADLTX validity documentation is legally significant when drug test results enter court proceedings and may be challenged. PCP at 25 ng/mL covers the dissociative class commonly required in court supervision orders. EtG and FEN close the alcohol and fentanyl gaps over the 12 panel baseline. Per NADCP best practice standards, comprehensive multi-class monitoring with documented specimen integrity is recommended. |
| Treatment Programs and Sober Living | 14 Panel KRA/K2/EtG/FEN | Kratom monitoring for patients using it as an opioid substitute, K2 synthetic cannabinoid detection for programs with documented Spice use, 80-hour alcohol monitoring via EtG, fentanyl concurrent use detection via FEN | KRA at 500 ng/mL and K2 at 50 ng/mL are the two substance panels most likely to be needed by treatment programs dealing with polydrug-using populations who use legal substance workarounds. Both pass every standard 12 panel screen. Per SAMHSA MAT guidelines, comprehensive concurrent substance monitoring including emerging substances is required. EtG covers the weekly alcohol monitoring interval. |
| Workplace and Staffing Programs | 14 Panel EtG and FEN | Pre-employment, random, and post-accident workplace screening with the complete professional baseline, alcohol monitoring for safety-sensitive positions, fentanyl compliance per July 2025 SAMHSA mandate | The EtG/FEN card provides the cleanest 14 panel configuration for workplace programs: the complete professional baseline (AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC) plus EtG for alcohol monitoring and FEN for federal mandate compliance. No specialty additions beyond what a workplace program typically needs. No ADLTX required for standard workplace use. |
| Correctional Facilities | 14 Panel PCP/EtG/FEN/ADLTX Multi Dip Card | Institutional drug screening with documented specimen validity (ADLTX), fentanyl supply detection, alcohol monitoring, PCP coverage, full stimulant and opioid baseline | ADLTX prevents specimen dilution evasion in institutional collection settings. Fentanyl is confirmed in drug supply in all 50 US states per CDC overdose data. EtG closes the alcohol monitoring gap between scheduled collections. PCP at 25 ng/mL covers the dissociative class. The combination of all five capabilities in one $1.39 card makes this the most operationally efficient 14 panel option for institutional programs. |
| Pain Management and MAT Clinics | 14 Panel PCP/EtG/KRA (no THC) | Kratom self-management monitoring for patients using it as an adjunct or substitute for prescribed opioids, EtG alcohol abstinence documentation, FEN for fentanyl concurrent use or prescription compliance, complete opioid baseline (BUP, MTD, OPI, OXY) for MAT and pain compliance | Programs where kratom monitoring is a priority alongside PCP and EtG, but where cannabis is not a monitored substance (legal jurisdiction or no cannabis supervision condition), use the no-THC KRA configuration to maximize the 14 panel positions on the substances most relevant to their population. KRA at 500 ng/mL provides kratom detection. The complete four-panel opioid suite (BUP/10ng, MTD, OPI/300, OXY/100) provides full MAT compliance coverage. |
The 14 Panel KRA/K2/EtG/FEN Dip Card: Closing the Two Detection Gaps Most Documented in Treatment Populations at $1.39
No standard 12 panel drug test at any configuration detects Kratom or K2 Synthetic Cannabinoids. Neither substance triggers any standard antibody panel — Kratom because its alkaloid compounds are structurally distinct from morphine, oxycodone, buprenorphine, and methadone; K2 because synthetic cannabinoid compounds are structurally distinct from delta-9-THC. Both are legally obtainable in most US states, both are documented in opioid-adjacent and recovery populations, and both pass standard drug screening completely undetected.
The 14 Panel KRA/K2/EtG/FEN Dip Card from 12 Panel Now adds dedicated KRA at 500 ng/mL and K2 at 50 ng/mL panels to the standard opioid, stimulant, and benzodiazepine baseline alongside EtG/300 and FEN/20, providing point-of-care detection for both substances in the same card at $1.39. Per NIDA K2/Spice data, synthetic cannabinoids are significantly documented in residential recovery settings. Per NIDA herbal drug research, kratom's opioid receptor activity and dependence potential make it a documented monitoring gap in MAT programs. For treatment programs dealing with polydrug-using populations who use both legal-substance workarounds, this single card provides the only available combined point-of-care detection solution.
14 Panel vs 12 Panel Dip Card: The Specific Panels That Change and Which Programs Should Upgrade
The upgrade from 12 panel to 14 panel dip card adds two panels to the standard professional baseline across every configuration: EtG at 300 ng/mL and one additional specialty panel (which varies by card). The practical question for a program considering this upgrade is: does my program currently need alcohol monitoring via EtG, and does my program currently need fentanyl detection via FEN? If both answers are yes, the 14 panel dip card is the appropriate upgrade. If only FEN is needed without EtG, the 13 panel FEN/TCA card at $1.29 may be more appropriate.
The five configurations in the 14 panel range then add a further specialty panel beyond EtG and FEN to reach 14: PCP and BAR as the classical forensic baseline additions (on three of the five cards), KRA for kratom detection, K2 for synthetic cannabinoid detection, and ADLTX for specimen validity documentation. Programs that currently run a 12 panel card plus a standalone EtG strip (typically $0.39 to $0.59 each) and a standalone fentanyl strip ($0.49) are spending approximately $0.88 to $1.08 in additional per-event cost. The 14 panel EtG/FEN card consolidates all three into a single $1.39 card — reducing per-event cost, simplifying the collection workflow, and eliminating the risk of documentation error from managing multiple separate card results simultaneously. Contact 12 Panel Now at 561-897-9238 for bulk pricing across all five configurations.
What Does “Forensic Use Only” Mean for 14 Panel Dip Cards?
- 1. What It Means
A “Forensic Use Only” label indicates that the 10 panel dip card:
Has not undergone FDA 510(k) clearance as a medical diagnostic device
Is intended for screening and compliance monitoring purposes only
Is designed for use in controlled environments such as workplace, legal, or institutional testing programs
14 Panel Dip Card Frequently Asked Questions
The best choice depends on your testing goals. Consider whether you need screening for substances like Kratom, synthetic cannabinoids, specimen validity checks, or a traditional workplace testing panel.
Yes. Many organizations use multiple configurations to meet the needs of different departments, facilities, or testing populations.
Specimen validity testing helps identify potentially altered, diluted, or substituted samples, supporting greater confidence in screening results.
They are frequently used in healthcare, workplace screening, corrections, treatment centers, transportation, and community supervision programs.
Yes. Expanded panels allow organizations to monitor additional substances that may become concerns within their testing population.
Multiple configurations allow programs to select a test that aligns with specific monitoring requirements rather than paying for unnecessary panels.
Yes. Confirmatory laboratory testing is recommended before taking legal, employment, or disciplinary action.
Review the substances included in each version and determine which panels best match your organization's screening objectives.
Yes. Many organizations use it for scheduled and recurring screening programs where ongoing monitoring is required.
Yes. It can provide broader monitoring capabilities while maintaining a simple testing process.
Yes. The dip-card format is designed for convenient on-site screening without specialized laboratory equipment.
Results interpreted outside the recommended reading window may not be reliable, and retesting may be necessary.
It's a good practice to review testing requirements periodically to ensure the chosen panel still meets operational and compliance needs.
Not always. The most effective test is one that includes the substances most relevant to your specific program requirements.
Yes. It can be incorporated into workplace drug screening programs to help maintain safety and compliance standards.
Verify that the packaging is sealed, the expiration date is valid, and storage conditions have been properly maintained.
Yes. Bulk purchasing can help reduce per-test costs and ensure a consistent supply of testing devices.
Many manufacturers offer private-label and OEM opportunities for qualified distributors and resellers.
On-site screening provides faster preliminary results, streamlined workflows, and reduced administrative delays.
Standardized collection procedures, staff training, proper record-keeping, and consistent testing protocols can help improve overall program reliability.
Perfect for brochures, menus, and promotional materials, these cards combine functionality with a polished, professional look. Their unique folding design not only grabs attention but also enhances user experience, helping businesses communicate their message effectively while leaving a memorable impression.
14 Panel Dip Cards – Product Overview
The 14 Panel Dip Card is a sophisticated, rapid test for the detection of fourteen distinct substances within a single urine specimen.
This device offers healthcare professionals and employers a reliable solution for preliminary drug screening with results available in approximately five minutes.
Key attributes include:
-
User-friendly dip-and-read design, facilitating efficient and straightforward testing procedures
-
Capability to detect an extensive array of commonly abused drugs, such as amphetamines, cocaine, opioids, benzodiazepines, THC, among others
-
Precise and easily interpretable results, featuring distinct control and test lines to ensure clarity and accuracy
-
Suitable for diverse environments including medical facilities, workplace drug screening programs, and other professional settings requiring prompt and dependable substance detection
